Ketotifen suppression of NF1 neurofibroma growth over 30 years.

Abstract excerpt

A patient with NF1 was treated with oral ketotifen for 30 years since infancy. Review of the patient's course and treatment details establishes a basis for reconsideration of several fundamental precepts about NF1 pathogenesis. The data suggest a distinctive benefit to treating an NF1 patient wit...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Oral
• Share to Genes, Neurofibromatosis 1
• Share to Mast Cells